垂体ACTH瘤病理评估研究进展
DOI:
作者:
作者单位:

南京医科大学第一附属医院

作者简介:

通讯作者:

中图分类号:

基金项目:


Progress in pathological evaluation of ACTH-secreting pituitary adenomas
Author:
Affiliation:

the First Affiliated Hospital of Nanjing Medical University

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    分泌促肾上腺皮质激素(ACTH)的垂体腺瘤(垂体ACTH瘤)因过度分泌ACTH刺激双侧肾上腺皮质增生而引起高皮质醇血症,也称作库欣病(Cushing’s disease,CD),是内源性高皮质醇血症最常见的原因。垂体ACTH瘤可导致电解质紊乱,糖、脂代谢紊乱等一系列严重的临床症候群,累及全身多个脏器及系统。经蝶窦神经内镜手术是垂体ACTH瘤的一线治疗方法,可以得到较高的缓解率,但术后复发和持续状态仍然是垂体ACTH瘤治疗的一个未解决的问题。垂体ACTH瘤病理评估在确定病变性质、预测其预后及药物治疗选择方面均有重要的价值。本文就垂体ACTH瘤病理评估的相关进展进行综述,包括新的免疫组化标志物和镜下特殊表现。

    Abstract:

    Pituitary adenomas secreting adrenocorticotropin (ACTH),also known as Cushing's disease (CD),cause hypercortisolemia due to excessive secretion of ACTH stimulating bilateral adrenal cortical hyperplasia, which is the most common cause of endogenous hypercortisolemia. ACTH-secreting pituitary adenomas can lead to electrolyte disorders, sugar and lipid metabolism disorders and a series of serious clinical symptoms, involving multiple organs and systems in the whole body. Transsphenoidal neuroendoscopic surgery is the first-line treatment for ACTH-secreting pituitary adenomas and can achieve a high remission rate, but postoperative recurrence and persistent status are still an unsolved problem in the treatment of ACTH-secreting pituitary adenomas. The pathological evaluation of ACTH-secreting pituitary adenomas has important value in determining the nature of the lesion, predicting the prognosis and selecting the drug therapy. This article reviews the progress in the pathologic evaluation of ACTH-secreting pituitary adenomas, including new immunohistochemical markers and microscopic features.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2023-12-07
  • 最后修改日期:2024-02-26
  • 录用日期:2024-04-19
  • 在线发布日期:
  • 出版日期:
通知关闭
郑重声明